-
公开(公告)号:US20080269220A1
公开(公告)日:2008-10-30
申请号:US10592789
申请日:2005-03-14
申请人: Tsuneo Yasuma , Nobuyuki Negoro , Shinobu Sasaki
发明人: Tsuneo Yasuma , Nobuyuki Negoro , Shinobu Sasaki
IPC分类号: A61K31/5375 , A61K31/216 , C07C229/42 , A61K31/404 , C07D209/20 , A61K31/415 , C07D215/14 , A61P3/10 , A61K31/47 , C07D231/22 , A61K31/426 , C07D277/30 , C07D265/30
CPC分类号: C07C311/21 , C07C229/42 , C07C309/66 , C07C311/51 , C07C317/18 , C07C317/32 , C07C323/12 , C07C2601/02 , C07C2602/08 , C07D213/74 , C07D215/06 , C07D231/24 , C07D277/28 , C07D307/79 , C07D409/12 , C07D417/12 , C07F9/4006
摘要: A compound represented by the formula (1): wherein each symbol is as defined in the specification, and a salt thereof and a prodrug thereof unexpectedly have superior GPR40 receptor agonist activity, superior in the properties as a pharmaceutical product such as stability and the like, and can be a safe and useful pharmaceutical agent as a drug for the prophylaxis or treatment of GPR40 receptor related pathology or diseases such as diabetes and the like.
摘要翻译: 由式(1)表示的化合物:其中每个符号如说明书中所定义,并且其盐和其前体药物出人意料地具有优异的GPR40受体激动剂活性,作为药物性质如稳定性等优异 并且可以作为预防或治疗GPR40受体相关病理学或糖尿病等疾病的药物的安全有用的药剂。
-
公开(公告)号:US07786165B2
公开(公告)日:2010-08-31
申请号:US10592789
申请日:2005-03-14
申请人: Tsuneo Yasuma , Nobuyuki Negoro , Shinobu Sasaki
发明人: Tsuneo Yasuma , Nobuyuki Negoro , Shinobu Sasaki
IPC分类号: A61K31/335
CPC分类号: C07C311/21 , C07C229/42 , C07C309/66 , C07C311/51 , C07C317/18 , C07C317/32 , C07C323/12 , C07C2601/02 , C07C2602/08 , C07D213/74 , C07D215/06 , C07D231/24 , C07D277/28 , C07D307/79 , C07D409/12 , C07D417/12 , C07F9/4006
摘要: A compound represented by the formula (1): wherein each symbol is as defined in the specification, and a salt thereof and a prodrug thereof unexpectedly have superior GPR40 receptor agonist activity, superior in the properties as a pharmaceutical product such as stability and the like, and can be a safe and useful pharmaceutical agent as a drug for the prophylaxis or treatment of GPR40 receptor related pathology or diseases such as diabetes and the like.
摘要翻译: 由式(1)表示的化合物:其中每个符号如说明书中所定义,并且其盐和其前体药物出人意料地具有优异的GPR40受体激动剂活性,作为药物性质如稳定性等优异 并且可以作为预防或治疗GPR40受体相关病理学或糖尿病等疾病的药物的安全有用的药剂。
-
公开(公告)号:US08492430B2
公开(公告)日:2013-07-23
申请号:US13287639
申请日:2011-11-02
申请人: Tsuneo Yasuma , Nobuyuki Negoro , Masahiro Itou
发明人: Tsuneo Yasuma , Nobuyuki Negoro , Masahiro Itou
IPC分类号: A61K31/382
CPC分类号: C07D409/12 , C07D307/80
摘要: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
-
公开(公告)号:US20100144806A1
公开(公告)日:2010-06-10
申请号:US11989748
申请日:2006-07-28
申请人: Tsuneo Yasuma , Nobuyuki Negoro
发明人: Tsuneo Yasuma , Nobuyuki Negoro
IPC分类号: A61K31/426 , C07C69/753 , C07D335/02 , C07D305/06 , C07D277/38 , A61K31/216 , A61K31/382 , A61K31/337 , A61P3/00
CPC分类号: C07C229/46 , C07C62/34 , C07C69/757 , C07C2601/02 , C07D277/20 , C07D277/42 , C07D305/06 , C07D335/02
摘要: A compound of the formula (I): wherein each symbol is as defined in the description, a salt s thereof, and a prodrug thereof of the present invention unexpectedly have a superior GPR40 receptor agonist activity and superior properties as pharmaceutical products such as stability and the like, and can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor-related pathology or diseases in mammals.
摘要翻译: 式(I)的化合物:其中每个符号如本说明书中所定义,其盐及其前药意外地具有优异的GPR40受体激动剂活性和优异的性能,如药物产品如稳定性和 并且可以是用于预防或治疗哺乳动物中GPR40受体相关病理学或疾病的安全有用的药剂。
-
公开(公告)号:US20120046338A1
公开(公告)日:2012-02-23
申请号:US13287639
申请日:2011-11-02
IPC分类号: A61K31/382 , C07D307/84 , A61P3/10 , A61K31/343
CPC分类号: C07D409/12 , C07D307/80
摘要: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
摘要翻译: 本发明提供由式(I)表示的化合物:其中每个符号如说明书中所定义,或其盐。 化合物或其盐或其前药具有GPR40受体功能调节作用,并且可用作胰岛素促分泌素或用于预防或治疗糖尿病等的药剂。
-
公开(公告)号:US20060258722A1
公开(公告)日:2006-11-16
申请号:US10558846
申请日:2004-05-28
申请人: Tsuneo Yasuma , Nobuyuki Negoro , Kohji Fukatsu
发明人: Tsuneo Yasuma , Nobuyuki Negoro , Kohji Fukatsu
IPC分类号: A61K31/428 , A61K31/381 , A61K31/353
CPC分类号: C07C69/734 , C07C59/64 , C07C59/68 , C07C59/72 , C07C2601/02 , C07C2602/10 , C07D277/42
摘要: The present invention aims at providing a novel fused ring compound having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes, more particularly, a compound represented by the formula: wherein Ar is an optionally substituted cyclic group, ring A is a ring optionally further substituted (provided that the ring is not thiazole, oxazole, imidazole and pyrazole), Xa and Xb are each independently a bond or a spacer having a main chain of 1 to 5 atom(s), Xc is O, S, SO or SO2, ring B is a 5- to 7-membered ring, Xd is a bond, CH or CH2, is a single bond when Xd is a bond or CH2, or a double bond when Xd is CH, and R1 is an optionally substituted hydroxy group, and a salt thereof.
摘要翻译: 本发明的目的在于提供一种具有GPR40受体功能调节作用的新型稠环化合物,可用作胰岛素促分泌素或用于预防或治疗糖尿病的药剂,更具体地,由下式表示的化合物:其中Ar为 任选取代的环状基团,环A为任选进一步取代的环(条件是该环不是噻唑,恶唑,咪唑和吡唑),Xa和Xb各自独立地为键或具有1至5个主链的间隔基 X是O,S,SO或SO 2,环B是5-至7-元环,Xd是键,CH或CH 2, ,是单键,或当Xd为CH时为双键,R 1为任选取代的 羟基及其盐。
-
公开(公告)号:US07732626B2
公开(公告)日:2010-06-08
申请号:US12308699
申请日:2007-06-26
IPC分类号: C07D307/80
CPC分类号: C07D409/12 , C07D307/80
摘要: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
摘要翻译: 本发明提供由式(I)表示的化合物:其中每个符号如说明书中所定义,或其盐。 化合物或其盐或其前药具有GPR40受体功能调节作用,并且可用作胰岛素促分泌素或用于预防或治疗糖尿病等的药剂。
-
公开(公告)号:US20070149608A1
公开(公告)日:2007-06-28
申请号:US10584481
申请日:2004-12-24
申请人: Tsuneo Yasuma , Shuji Kitamura , Nobuyuki Negoro
发明人: Tsuneo Yasuma , Shuji Kitamura , Nobuyuki Negoro
IPC分类号: A61K31/4015 , A61K31/382 , A61K31/337 , A61K31/34 , A61K31/165 , A61K31/192
CPC分类号: C07D207/08 , C07C59/68 , C07C69/734 , C07C205/34 , C07C217/20 , C07C233/18 , C07C309/66 , C07C317/18 , C07C323/12 , C07C2601/02 , C07D207/27 , C07D213/30 , C07D277/24 , C07D295/088 , C07D295/185 , C07D295/205 , C07D305/06 , C07D309/12 , C07D333/32 , C07D335/02 , C07F9/4006
摘要: The present invention provides a novel compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof having a superior GPR40 receptor function modulating action, which can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. They unexpectedly show superior GPR40 receptor agonist activity, and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor related diseases in mammals.
摘要翻译: 本发明提供由式(I)表示的新化合物,其中每个符号如本说明书中所定义,其具有优异GPR40受体功能调节作用的盐及其前药,其可用作胰岛素促分泌素, 用于预防或治疗糖尿病等的药剂。 它们意外地显示出优异的GPR40受体激动剂活性,并且还表现出作为药物产品的优异性质,例如稳定性等。 因此,它们可以是用于预防或治疗哺乳动物中GPR40受体相关疾病的安全有用的药剂。
-
公开(公告)号:US08088821B2
公开(公告)日:2012-01-03
申请号:US12659695
申请日:2010-03-17
申请人: Tsuneo Yasuma , Nobuyuki Negoro , Masahiro Itou
发明人: Tsuneo Yasuma , Nobuyuki Negoro , Masahiro Itou
IPC分类号: A61K31/343 , C07D307/80
CPC分类号: C07D409/12 , C07D307/80
摘要: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
摘要翻译: 本发明提供由式(I)表示的化合物:其中每个符号如说明书中所定义,或其盐。 化合物或其盐或其前药具有GPR40受体功能调节作用,并且可用作胰岛素促分泌素或用于预防或治疗糖尿病等的药剂。
-
公开(公告)号:US20100197761A1
公开(公告)日:2010-08-05
申请号:US12659695
申请日:2010-03-17
IPC分类号: A61K31/343 , C07D409/12 , C07D307/80 , A61K31/382 , A61P31/10
CPC分类号: C07D409/12 , C07D307/80
摘要: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
-
-
-
-
-
-
-
-
-